Durvalumab,Tremelimumab
AstraZeneca,Pfizer,AstraZeneca
['tremelimumab', 'imfinzi', 'lung', 'astrazeneca']
#astrazeneca reported that #imfinzi and #tremelimumab with #chemotherapy demonstrated sustained survival benefit in #metastatic #nonsmallcelllungcancer nearly doubling the number of patients alive after three years vs. chemotherapy #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.